Biopharma Cold Chain Logistics Market is valued at USD 18.2 billion in 2021. It is expected to reach a value of USD 29.6 billion by 2028, growing at a CAGR of 7.3% from 2022 to 2028. The global market provides a detailed overview and which has been segmented by component and region. By component, the Biopharma Cold Chain Logistics market has been segmented into Storage (Warehouse, Refrigerated Container), Transportation (Sea Freight Logistics, Air Freight Logistics, Overland Logistics), Monitoring Components (Hardware (Sensors, RFID Devices, Telematics, Networking Devices) Software. According to precision business insights, the storage segment is predicted to register the fastest growth rate during the forecast period.
In August 2020, UPS was building two giant freezer farms capable of super-cooling millions of vials of a COVID-19 vaccine, preparing for the day when it may need to deliver the medicine at high speed across the world.